Caption Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Caption Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,000	Closed	-$318K	–	1720
2026 Q1	$318K	Sell	8,000 -130,800	-94%	-$3.35M	﹤0.01%	1289
2025 Q4	$3.47M	Sell	138,800 -191,800	-58%	-$4.86M	0.02%	630
2025 Q3	$8.02M	Buy	330,600 +301,000	+1,017%	+$5.35M	0.06%	339
2025 Q2	$389K	Buy	29,600 +13,700	+86%	+$174K	﹤0.01%	1170
2025 Q1	$229K	Buy	+15,900	New	+$260K	﹤0.01%	1248

Caption Management's CNTA Position: Q2 2026 in Review

Caption Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 274,116 shares — an estimated $10.9M sold.

Caption Management first reported a position in CNTA in Q1 2025 and held it in 3 quarters. The position peaked at $10.9M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Caption Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Caption Management sold 274,116 Centessa Pharmaceuticals shares in Q2 2026, an estimated $10.9M.
Caption Management first reported a position in Centessa Pharmaceuticals in Q1 2025 and held it in 3 quarters.
Caption Management's Centessa Pharmaceuticals position peaked at $10.9M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.